These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7528495)

  • 1. [Involvement of epidermal growth factor receptor (EGFR) in the etiopathogenesis of prostatic proliferative processes].
    Moreno Sierra J; Fernández Lucas C; Maestro de las Casas ML; Ortega Heredia MD; López Asenjo J; Resel Estévez YL
    Arch Esp Urol; 1994 Sep; 47(7):685-9. PubMed ID: 7528495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.
    Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN
    J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue.
    Turkeri LN; Sakr WA; Wykes SM; Grignon DJ; Pontes JE; Macoska JA
    Prostate; 1994 Oct; 25(4):199-205. PubMed ID: 7521960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.
    Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C
    Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of growth factors in the etiopathogenesis of benign prostatic hyperplasia].
    Blanco Jiménez E; Moreno Sierra J; Fernández Lucas C; Begara Morillas F; Hermida Gutiérrez J; Resel Estévez L
    Actas Urol Esp; 1994 May; 18 Suppl():359-64. PubMed ID: 7521109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells.
    Itoh N; Patel U; Skinner MK
    Endocrinology; 1998 Mar; 139(3):1369-77. PubMed ID: 9492074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative determination of epidermal growth factor urothelial receptor (EGFR) in superficial and invasive bladder carcinoma].
    Moreno Sierra J; Maestro de las Casas M; Ortega Heredia MD; Hermida Gutiérrez J; Resel Estevez L
    Actas Urol Esp; 1994 Mar; 18(3):215-20. PubMed ID: 8036950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N; Karyotis I; Delakas D; Spandidos DA
    Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor-related peptides in human prostatic fluid: sources of variability in assay results.
    Gann PH; Chatterton R; Vogelsong K; Grayhack JT; Lee C
    Prostate; 1997 Sep; 32(4):234-40. PubMed ID: 9288181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of c-Met/hepatocyte growth factor receptors in human prostatic adenocarcinoma.
    Inoue K; Chikazawa M; Karashima T; Iiyama T; Kamada M; Shuin T; Furihata M; Ohtsuki Y
    Acta Med Okayama; 1998 Dec; 52(6):305-10. PubMed ID: 9876767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin growth factor I (IGF-I) in normal, hyperplastic, and tumor prostatic tissue].
    Téllez Martínez-Fornés M; Balsa J; Maganto Pavón E; Jiménez Cidre M; Burgos Revilla FJ
    Actas Urol Esp; 1996 May; 20(5):409-13. PubMed ID: 8766797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular endothelial growth factor in malignant and non malignant prostatic tissue: Association with tumor recurrence at one year after prostatectomy].
    Acuña P; Ellwanger A; Ramírez A; Cardemil F; Vega J; Casalino R; Madrid E
    Rev Med Chil; 2013 Feb; 141(2):153-9. PubMed ID: 23732486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.